PUK12 COST-EFFECTIVENESS OF ACE INHIBITOR THERAPY TO PREVENT DIALYSIS IN NON-DIABETIC NEPHROPATHY—INFLUENCE OF THE ACE INSERTION / DELETION POLYMORPHISM

Stefan Vegter; Annalisa Perna; Wâtse Hiddema; Piero Ruggenenti; Giuseppe Remuzzi; Gerjan Navis; Maarten J. Postma

doi:10.1016/s1098-3015(10)74522-8

Back

PUK12 COST-EFFECTIVENESS OF ACE INHIBITOR THERAPY TO PREVENT DIALYSIS IN NON-DIABETIC NEPHROPATHY—INFLUENCE OF THE ACE INSERTION / DELETION POLYMORPHISM

Article 2009 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2009

Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism

Stefan Vegter, Annalisa Perna, Wâtse Hiddema, Piero Ruggenenti, Giuseppe Remuzzi, Gerjan Navis, Maarten J. Postma

Article2008

ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy

Hans‐Henrik Parving, Dick de Zeeuw, Mark E. Cooper, Giuseppe Remuzzi, Nancy Liu, Jared Lunceford, Shahnaz Shahinfar, Peggy H. Wong, Paulette A. Lyle, Peter Rossing, Barry M. Brenner

Article2003

Add-On Anti–TGF-β Antibody to ACE Inhibitor Arrests Progressive Diabetic Nephropathy in the Rat

Ariela Benigni, Carla Zoja, Daniela Corna, Cristina Zatelli, Sara Conti, Marco Campana, Elena Gagliardini, Daniela Rottoli, Cristina Zanchi, Mauro Abbate, Steve Ledbetter, Giuseppe Remuzzi

Article2008

Angiotensin Converting Enzyme Insertion/Deletion Polymorphism and Renoprotection in Diabetic and Nondiabetic Nephropathies

Piero Ruggenenti, Paola Bettinaglio, Franck Pinares, Giuseppe Remuzzi

Article2023

Endothelial Glycocalyx of Peritubular Capillaries in Experimental Diabetic Nephropathy: A Target of ACE Inhibitor-Induced Kidney Microvascular Protection

Monica Locatelli, Daniela Rottoli, Mahmoud Rayan, Mauro Abbate, Daniela Corna, Domenico Cerullo, Susanna Tomasoni, Giuseppe Remuzzi, Carla Zoja, Ariela Benigni, Daniela Macconi